Figure AI says three of its humanoid robots crossed more than 24 hours of continuous autonomous operation after a test that was supposed to last only eight hours kept running. The California-based ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Silicon Valley's hottest livestream this week is a humanoid robot clocking in for a warehouse shift.

FedEx plans to increase its footprint at Memphis International Airport. On Jan. 20, California-based construction firm GFT filed an administrative site plan review application with the Memphis and ...

Are you a postal or other logistics worker? Send us a report on conditions in your facility by filling out the form at the end of this article. On Sunday, November 16, at 3:00 p.m. US Eastern Time, ...

I’m a big proponent of IUDs. The birth control option, formally known as an intrauterine device, lasts years (between three and 12, depending on the type) and it’s a “set it and forget it” solution.

A new medical device coming the United States could be a game-changer for some women's health procedures, such as IUD insertion. Carevix is the world’s first suction-based cervical stabilizer, ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Have you ever grouped data in Excel only to find your months sorted alphabetically instead of chronologically? It’s a frustrating quirk of the GROUPBY function, one that can turn a clean dataset into ...

If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle the easiest pieces first. But this kind of sorting has a cost.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Earlier ...

Mindfulness and Tai Chi for Cancer Health (MATCH) Study: Primary Outcomes of a Preference-Based Multisite Randomized Comparative Effectiveness Trial At data cutoff (December 10, 2024), 244 patients ...